Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,937 DKK | +0.31% | +0.55% | -10.12% |
21/05 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
21/05 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 1.82TCr | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, Nine Months 2022 Earnings Call, Nov 09, 2022